United Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNITED THERAP, and what generic alternatives to UNITED THERAP drugs are available?
UNITED THERAP has four approved drugs.
There are twenty-four US patents protecting UNITED THERAP drugs. There is one tentative approval on UNITED THERAP drugs.
There are one hundred patent family members on UNITED THERAP drugs in nine countries.
Summary for United Therap
| International Patents: | 100 |
| US Patents: | 24 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 4 |
| Patent Litigation for United Therap: | See patent lawsuits for United Therap |
| PTAB Cases with United Therap as patent owner: | See PTAB cases with United Therap as patent owner |
Drugs and US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-002 | Dec 20, 2013 | RX | Yes | No | 7,544,713 | See Plans and Pricing | See Plans and Pricing | ||||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | RX | Yes | Yes | 9,278,901 | See Plans and Pricing | See Plans and Pricing | ||||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | RX | Yes | Yes | 9,604,901 | See Plans and Pricing | Y | See Plans and Pricing | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | RX | Yes | Yes | 9,593,066 | See Plans and Pricing | Y | See Plans and Pricing | |||
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-002 | May 21, 2002 | AP | RX | Yes | Yes | 8,653,137 | See Plans and Pricing | See Plans and Pricing | |||
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-002 | May 21, 2002 | AP | RX | Yes | Yes | 10,076,505 | See Plans and Pricing | Y | See Plans and Pricing | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-001 | Dec 20, 2013 | 5,153,222 | See Plans and Pricing |
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-004 | May 21, 2002 | 6,765,117 | See Plans and Pricing |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | 6,765,117 | See Plans and Pricing |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | 5,153,222 | See Plans and Pricing |
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-004 | May 21, 2002 | 5,153,222 | See Plans and Pricing |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | 5,153,222 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for UNITED THERAP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 10 mg/mL, 20 mL vial | ➤ Subscribe | 2011-12-02 |
| ➤ Subscribe | Inhalation Solution | 0.6 mg/mL, 2.9 mL ampules | ➤ Subscribe | 2015-04-13 |
| ➤ Subscribe | Extended-release Tablets | 0.25 mg and 1 mg | ➤ Subscribe | 2016-05-19 |
| ➤ Subscribe | Injection | 1 mg/mL, 2.5 mg/mL, and 5 mg/mL, 20 mL vial | ➤ Subscribe | 2012-12-07 |
| ➤ Subscribe | Extended-release Tablets | 2.5 mg | ➤ Subscribe | 2015-12-24 |
International Patents for United Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2427054 | See Plans and Pricing |
| Japan | 5841554 | See Plans and Pricing |
| Japan | 2007514750 | See Plans and Pricing |
| South Korea | 20060123483 | See Plans and Pricing |
| Japan | 6307061 | See Plans and Pricing |
| China | 1917866 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
